key: cord-356062-7q5n4t97
authors: nan
title: Cumulative pharmacological activity index volumes 1-30
date: 2005-12-31
journal: Studies in Natural Products Chemistry
DOI: 10.1016/s1572-5995(05)80101-2
sha: 
doc_id: 356062
cord_uid: 7q5n4t97

Publisher Summary This chapter lists the important subjects on pharmacological activity that are discussed in the publication Studies in Natural Products Chemistry, Volumes 1–30, such as abdominal constriction test, acanthoic acid, acetaminophen, Parkinson's disease, photodynamic activity, prostaglandins, and oleanolic acid. The terms are mentioned along with the page numbers in which they are discussed in the publication.

use of Psycotria colorata in 30:205 19(4--+ 3)-Abeo-8 c~, 13(S)-epoxylabda-4(18), 14-diene 29:102 activity in EBV bioassay system 29:102 19-nor-Abieta-4( 18),8,11,13-tetraen-7one 29:100 activity in EBV assay system 29:100 Abieta-8,11,13-trien-7-one 29:99 activity in EBV assay system 29:99 18-nor- 11, 7a, 15triol 29:99 activity in EBV assay system 29:99 11, 15, activity in EBV assay system 29:99

Abieta-8,11,13-triene-7o~,l 5,18-triol 7acetate 29:99 activity in EBV assay system 29:99 Abietic acid 29:99 activity in TPA assay system 29:99 activity in CRG (+)-5-epi-Acetomycin 10:447 antitumor activity of 10:447 2(x-Acetoxy-14-hydroxy-15-iso-valeroyloxy-9-oxo-costunolide 29:89 activity in NFkB assay system 29:89 activity in TNF(x assay system 29:89 9cx-Acetoxy-4 ~, 15-epoxymiller-1 ( 10)Zenolide 29:89 activity in NFkB assay system 29:89 3~-Acetoxy-813-isobutyryloxy-reynosin 29:87 activity in Mam-2 assay system 29:87 activity in DIF assay system 29:87 15-Acetoxy-9 ~-hydroxy-8 [3-methacryloyloxy-14-oxo-acanthospermolide 29:89 activity in NFkB assay system 29:89 15-Acetoxy-9cx-methacryloyloxy-8 ~hydroxy-14-oxo-acantho-spermolide 29:89 activity in NFkB assay system 29:89 3-Acetoxycostunolide 29:89 activity in NFkB assay system 29:89 15-Acetoxy-eremantholide B 29:89 activity in NFkB assay system 29:89 activity in TNF~ assay system 29:89 9~-Acetoxy-miller-1 ( 10) 30:191, 192, 203 development of 30:192, 203 use of 30:191 Analgesic effects 26:401, 403, 404, 406, 416, 418; 30:205, 208 5:512,747;10:78, 117;11:134;12:398;14:145;20:245, 712 ;21:21,108,109,190,207,213,214, 230,237,262,266,267,275,284,601, 615 ;23:41,126,164,235,258,355,468, 375,472,473,531,534,800;24:573, 856,857;26:226,1002;28:140,688; 30:328 11:130;12:192; 17:283 ;21:188,202,223,239,364,437; 23:649;24:953-954 21:186,192,197, 203,206,213,214,218,221,226, 227,233-235,223,238,240,389, 391,399,404,405,435,599-662; 22:626;23:3,4,271,341,344,348, 468,473,798,801354,368 ;26:227, 228,553,1098;28:4;66,473,475,686; 30:327,738,629 against Candida albicans 30:327,629 from Hypericum roeperanum 30:629 of (E)-8(17), 12-1abdadiene-15,16-dial 23:798 of (E)-8b, 17-epoxylabd-12-ene-15,16-deol 23:798 of (E)-8 [3,17-epoxylabol-12-ene-15,16- 19:511,748;21:132, 133,149,252,269,664,665 ;23:316, 533,534,687,704 ;24:742,743 ;30:226, 396,397 13:647;17:137,376;18:775;21:130, 134,153,152,312,591,594,690,616, 656,657;22:93,119,307,345,361; 23:158,297,512,602,832;25:43; 26:340,341,343,391,398,400,401, 403,404,406,415,418,482,556,558, 741,759,1035 ;27:660,858 ;28:200, 257,293 ;671,844;30:206,207,224, 225,292,320,689 21:674,744; 26:229,790,813,887,789,790,791, 800,805,807,810,811,821,828,830 -microbial activity 5:752;10:443; 15:327-339;18:776-778;21:153, 235,257,401,571,573,591,596,597, 599,606;22:626;23:94,153,180,233, 237,249,262,268,267,346,353,522; 24:64,69,206,330,331-334,402,403, 404,406,417,418,443,470,485,859, 1091,1092,1189;26:64,330,401,402, 1189;27:807;28:62,224,257,293; 28:698 22:308,321,345 ;23:395,534,535,742, 772,773,845 ;25:59;30:173,224,225, 289,320,321,524,561,743,745; 26:250,255,509,556,672,763,768, 887,1005,1006;28:4,16,17,63,179, 257,293 1:275,316-320-408; 17:17 ;21:137,405,420,435,436,638, 704,733;22:676;23:74,96,126,132, 139,395,445,522,696,721; 24:272-275 ;24:288,845,847,849; 25:43,430,431,438,450-453;26:56, 482,706;27:803;28:211,517,519,559, 560,566;30:3,28,29,55,56,58,59,64, 65,224,314,395,589,690,777,840 :461,563;10:608, 609,619,620; 17:146 ;21:132,148, 150,393,435,600,615,662,690,718; 22:307,361 ;23:233,268,233,346,395, 473,512,531,703;25:114;26:169,222, 224,226,344,452,741,759;27:482; 28:257,293 ;30:224,324-326,393,394, 395,398,401-405,407,410-412 132,148,162, 223,236,238,263,265,269,284,297, 366,388,390,410,419,421,431,571, 578,591,598,601,603,620,694 ;23:63, 93,95,108,111,129,126,107-152,153, 158,179,267,271,285,395-453, 455-485,491,497,642-643 ;739;24:25, 799,845 ;27:178,377,431,421,443, 693,778,801,924 ;24:353-376; 27:185-225,332,659;28:109,212,228, 229,340;29:743 ;30:4,26,172,175, 200,224,303,310,395,404,483,484, 485,495,496,497,499,562,588,603, 637,831,840,843, acaricidal enzymatic activity 24:995-998 tx-Cembra-2,7,11-triene-4,6-diol 29:100 activity in EBV assay system 29:100 activity in PKC assay system 29:100 activity in skin-1 assay system 29:100 activity in ODC assay system 29:100 ~-Cembra-2,7,11-triene-4,6-diol 29:100 activity in EBV assay system 29:100 activity in skin-1 assay system 29:100 activity in ODC assay system 29:100 of (-)-deoxypodophyllotoxin 30:589 of (-)-hemone 30:590 of (-)-nymphone 30:590 of (-)-yatein 30:590 of (+)-corytuberine 30:589 of (+)-epiaschantin 30:590 of (+)-epimagnolin 30:590 of (+)-epiyangambin 30:590 of (+)-hernovine 30:589 of (+)-laurotetanine 30:589 of (+)-magnoflorine 30:589 of (+)-malekulatine 30:590 of (+)-N-formyldehydroovigerine 30:589 of (+)-N-formylnornantenine 30:589 of (+)-N-formylovigerine 30:589 of (+)-N-hydroxyhemangerine 30:589 of (+)-N-methylhemangerine 30:590 of (+)-ovigerine 30:590 of (+)-ovihernangerine 30:590 of (+)-vateamine-2' [3-N- 134,136,150, 174,257,259,260,262,263,265,267, 269,270,271,273,274,284,311,364, 410,634,643,656,661,690,704,744; 23:96,97,187,218,238,249,250,253, 255,272,274,277,290,292,299,308, 317,701,274 ;24:294,352,740,867; 26:212-213,1185 as anti-fungal agents 24:406 2 [3,5-Epoxy-5,10-dihydroxy-6c~ange lo y-lo xy-9 [3-is obutylo xygermacran-8ot, 12-olide 29:89 activity in iNOS assay system 29:89 activity in NFkB assay system 29:89 7 a, 8 c~-Ep oxy-6 or-hydro xyabieta-9(11), 13-dien-12-one 29:99 activity in EBV assay system 29:99 9,10or-Epoxy-9,10-seco-abieta- 4-O-phenyl-2-propionyl-Neu5Ac-cx2Me 27:123 4-t-butyl-dimethyl-silyl ether 27:127 5-azido-5-deamino-Neu5Ac-c~2Me 27:119 5-N-benzyloxycarbonyl-Neu-cx2Me 27:119 5-N-propionyl-Neu-c~2Me 27:119 7-deoxy-Neu5 Ac-c~2Me 27:123,127 8-amino-8-deoxy-Neu5 Ac 27:121,122 8-azido-8-deoxy-Neu5Ac 27:121,122 8-tosyl-Neu5AcMe ester 27:121,122 9-amino-9-deoxy-Neu5 Ac 27:121,122 9-amino-9-deoxy-Neu5Ac-c~2Me 27:119 9-azido-9-deoxy-Neu5 Ac 27:121,22 9-azido-9-deoxy-Neu5Ac-c~2Me 27:119 9-O-acetyl-Neu5 Ac-( ,590 activity of (-)-deoxypodophyllotoxin in 30:589 activity of (-)-hemone in 30:590 activity of (-)-nymphone in 30:590 activity of (-)-yatein in 30:590 activity of (+)-corytuberine in 30:589 activity of (+)-epiaschantin in 30:590 activity of (+)-epimagnolin in 30:590 activity of (+)-epiyangambin in 30:590 activity of (+)-hernovine in 30:589 activity of (+)-laurotetanine in 30:589 activity of (+)-magnoflorine in 30:589 activity of (+)-malekulatine in 30:590 activity of (+)-N-activity of hydroxyhernangerine in 30:589 activity of (+)-N-formylnornantenine in 30:589 activity of (+)-N-formyldehydroovigerine in 30:589 activity of (+)-N-formylovigerine in 30:589 activity of (+)-ovigerine in 30:590 activity of (+)-ovihernangerine in 30:590 activity of (+)-vateamine-2'13-Noxide in 30:590 activity of 7-formyldehydrohernangerine in 30:589 activity of 7-formyldehydronornantenine in 30:589 activity of 7-formyldehydroovigerine in 30:589 activity of 7-hydroxy-6-methoxy- 12-Hydroxy -6,7-seco-abieta-8,11,13trien-6,7-dial 29:99 activity in EBV assay system 29:99 7-Hydroxy-6-methoxy-1-methyliso- 22:510,512,513,516,518,519, 521,522,525-529,531,534 Achyranthes aspera L 9,459,503,753,754,311; 17:313,441 ;20:108-113,273,613; 24:215,228-232,503-509,739-798; 26:229,790,813,887;30:560,562,567, 570,590 

Chemo-differentiation therapy 30:498 of acute monocytic leukemia

Chemopreventive activity 30:591,597, 766 in mouse mammary organ culture model 30:591 in vitro 30:597 in vitro bioassays for 30:591 of Chlorella vulgaris 30:766 ofisoquinoline alkaloids 30:597 of lignans 30:597 Chemopreventive agent 26:219 genkwanin as

Chemopreventive efficacy 27:386 of limonene carcinogenesis 27:386 Chemoprophylaxis 26:674 Chemosensitizers 30:595 antimalarial drugs as 30:595 Chemotaxonomic markers 26:1128 Chemotherapeutic agent 30:5,330,742 atovaquone 30:330 for colon cancer 30:5 for multi-drug resistant cancers 30:5 for ovarian cancer 5 for taxol-resistant breast cancer

Chemotherapeutic intervention 30:397 targets for

Chemotherapy drug 27:436 antitumor activity of 27:436 Chest pain 30:203 use of ginseng root in 30:203 Childhood disintegrative disorder (CDD)

Gram-negative bacteria 30:693 Maytenus species against

Gram-positive bacteria 23:68;30:629, 693 actamycin against 23:68 antimicrobial activity of 30:629 inhibitor

Maytenus species against

Grandiflorolic acid 29:100 activity in EBV bioassay system

Grandiflorolic acid angelate 29:100 activity in EBV bioassay system

Grandisin 26:230 trypanosomicidal activity of

Grandmal seizures

Granulocyte phagocytosis 26:47,55 ofjenisseensosides C 26:47,55 ofjenisseensosides D

Green tea 27:417,420 biological activity of

757 effect of general analogues on PGF2 NA-induced contraction

Griseofulvin 24:934 as anti-fungal agents

Grob-type fragmentation 24:728,731 Growth 30:61 of tumor cells 30:61 Growth inhibition 17:142 Growth inhibitor activity 7:407

Guaiazulene 5:363,369 as an anti-inflammatory agent

Guidimacrin 27:831 antitumor mechanism

584 neurodegeneration 30:224 reperfusion injuries 30:224 respiratory disorders 30:224 role of free radicals in 30:224 Human growth hormone

Human HEK 293 cell line 30:781 biological response of

Human HL-60 leukemia cells 30:496 differentiation of 30:496 inhibition of 30:496 proliferation of

Human leukemia cells 18:269 Human leukocyte elastase 16:727 inhibitor

Human leukocyte elastase (HLE) 30:830,831,843 homologous sequences of 30:831 plasminogen activator (u-PA) 30:830 Human lung carcinoma 23:290;30:5 discodermolide against

Human lung carcinoma) 30:691 phenolic triterpenes against 30:691 Human medulloblastoma 23:290 Human melanoma 23:255 Human mesangial cell proliferation 30:308 in vitro

Human monoblastic leukemia cells 30:498 effect of hydroxyurea (HU) 30:498 growth inhibition of 30:498 Human monoblastic leukemia U937 cells 30:498 growth inhibition of

Human neuroblastoma nbla-N-5 cells tamoxifen activity against 12:390 Human neuroblastoma SH-SY-5Y cells 12:390 Human neutrophils 12:390 Human neutropil protein kinase C 12:389 Human onchocerciasis 12:9 ivermectin for

Human papilloma virus 30:394 pathogenesis of 30:394 cause of hepatocellular carcinoma

Human Papilloma virus (HPV) 23:97

Human papilloma virus type 11 30:406 microbicidal compound against

Human papilloma virus type 40 30:406 microbicidal compound against 30:406 Human platelets 12:390 study of protein kinase C in 12:390 by staurosporine 12:390 Human rotavirus (HRV) 30:406,412 cause of dehydrating gastroenteritis 30:406 member of 30:406 reoviridae type of

Human serotonin transporter gene (SLC6A4) 30:376 regulation of neuronal activity

Human spermatozoa motility 21:675 Human synovial PLA2 25:697 inhibitor

anti-glycemic effects 24:902-904 anti-hyperglycemic effects of

-O-methyl-20-hydroxyecdysone activity in 29:28 pinnatasterone activity in 29:28 polypodine B 2-O-cinnamate activity in

Muscarinic AchR antagonists 21:56 Muscarinic antagonist 22:19 Muscarinic receptor 21:95

Muscarinic receptor antagonists 22:734 Muscarinic-l,2-receptor 21:95 Muscle pain 24:898 aconitine for relieving

activation effects of 24:906 medicinal uses of 24:906 protein kinase C activation effects 24:906 Muscular

P-388 (murine lymphocytic leukemia) 30:588 activity of (-)-deoxypodophyllotoxin against 30:588 activity of (-)-yatein against

P-388 lymphocytic leukemia cell 25:764 P388 mouse leukemia 12:390 staurosperine activity against

P-388 murine leukemia cells 21:411 Pachyman 5:288,317 antitumor activity of 5:317 Pachyrrhizus erosus 24:779,822-826 anti-feeding activity of 24:825 Pachyrrhizus palmatilobis 24:822 biological activity of 24:823 Paclitaxel

240 (+)-acetoxypinoresinol dimethyl ether as 26:241 arctigenin as 26:241 arctigenin methyl ether as 26:241 chamigrenal as 26:244 cinnamophilin as 26:240 dehydroschisandrol A as 26:245 denudatin as

458 FPTase inhibition by 24:458 Paw oederma 30:207 inhibition of 30:207 2-Pectenotoxin 19:580 cytoxic activity of 19:580 Pectinasic

Pectolinaringenin 30:725,748 antispasmodic activity of 30:748 Pedunculariside 29:84 activity in COX assay system 29:84 activity in EPP assay system

Pelargonidin (anthocyanidin) 29:585 effects on LELA 29:585 effects on

Penates sp. 28:713 as ~-glucosidase inhibitor 28:713

Penicillium turbatum 11:194 antibiotic A 26771B by 11:194 Penstemide 7:441 activity against P-388 lymphocytic leukemia

Penstemon rosseus 24:838 anti-fungal activity

Pentacyclic triterpenes 30:207 protein kinases inhibition by

564 in lipid autoxidation

3,4,6-P enta-O-gallo yl-~ -D-g luc o s e (galloyl ester) 29:589 effects on

229 biological activity of 28:229 8-Prenyleriodictyol 28:229 biological activity of 28:229 Prenylflavones 28:225 anti-human immunodeficiency virus (HIV) activity of 28:226 Prenylfiavonoid 30:207 antinocicieptive effect of

antitumor promoting activities of 29:720 as cytomegalovirus protease inhibitors 29:720 gastro-intestinal problems 29:720 use in Hodgkins disease 29:720 use in infections 29:720 use in lupus 29:720 use in osteomyelitis 29:720 use in Parkinson's disease 29:720 use in psoriasis 29:720 use in respiratory problems 29:720 use in skin ulcerations 29:720 use in syphilis 29:720 6-Prenylnaringenin

Prevention by chitosan 27:436 of myelotoxicity 27:436 Primary biliary cirrhosis 25:463 Primary granulosa cells 25:269 apoptosis in 25:269 Primary solid-tumor growth 30:64 effect of triterpenoids on 30:64 Pristimarin 30:692 cytotoxic activity of

PRL1 & PRL2 proproteins 29:592 effects on cysteine protease

851 Probes 27:332 activity of 27:346 Procurcumenol 29:90 activity in TNFct assay system

Procyanidin B 1 (dimeric flavan-3-ol) 29:580 effects on ACE

Procyanidin B2 (dimeric flavan-3-ol) 29:580 effects on ACE

Procyanidin B-5 3,3'-di-O-gallate 29:580 effects on ACE

Procyanidin C2 (trimeric flavan-3-ol) 29:580 effects on ACE 29:580 Procyanidin polymer (flavan-3-ol polymer) 29:580 effects on ACE

Prodrug monotherapy 21:157 natural anthracyclines for 21:157 Prodrugs 21:157 of natural anthracyclines

Pro-inflammatory cytokines 25:461 Pro-inflammatory substances 30:206 in chronic painful inflammatory diseases 30:206 Proliferation 30:368,378 effect of serotonergic neurotransmission on 30:368 serotonin action on 30:378 Prolysine 25:388 prophylactic effects

Pro-nociceptive prostaglandins 30:192 in inflammation

Pro-nociceptive transmitter 30:194 release inhibition of 30:194 Prooxidant activities 30:745 in thiobarbituric acid assays 30:745 of chemiluminescence 30:745 of tert-butyl hydroperoxide 30:745 Prooxidant property 30:524 of carotenoids 30:524 Prophylactic drugs

Prostaglandin E2-dependent flavonoids cytoprotection effect

PGH2) 25:595 Prostaglandin inhibitors 30:192 clinical use of 30:192 use in rheumatism 30:192 use in osteoarthritis 30:192 use in headache 30:192 use in dental surgery

anticancer clavulones 16:366 as antiviral compound 24:541-544 as pain mediator 30:192 in mast cells 30:192 nociceptive effect of

Prostate cancer prevention 30:525 role of lycopene

Protease inhibitor proteins from plants 29:596 effects on metallo

Protease inhibitors 24:487,488

567 cereal bifunctionals as 29:567 chymotrypsin as 29:568 destructive potential of 29:568 in Alzheimer's disease 29:567 in angiogenesis 29:567 in cancer inflammatory disease 29:567 in protozoal infection 29:567 in viral infection 29:567 Kunitz as 29:567 mustard family of 29:567 of metallocarboxypeptidase 29:567 ofserine protease 29:567 pepsin as 29:568 phytocystatins as 29:567 potato type 29:567 proteins as 29:567 serpin as 29:567 trypsin as 29:568 Proteases 24:1005;29:567 enzymatic activity 24:1005 in apoptosis 29:567 in blood clotting 29:567 in cell division 29:567 in digestion 29:567 in extracellular matrix digestion 29:567 in inflammatory responses 29:567

Protein kinase A (PKA) 192 in regulation of ionotropic receptors

Protein kinase activity 28:677 ofxestoquinolide

Protein kinase C (PKC) activator 30:70 Protein kinase C inhibition 24:573; 25:46,488 by xestocylamine 24:573 Protein kinase inhibition 30:207 by pentacyclic triterpenes

Protein phosphatase inhibitors 27:874 Protein phosphatases 25:707 inhibitor of 25:707 Protein synthesis 30:407 inhibitor of 30:407 Protein transduction domain (PTD)

Proteinaceous receptor 25:371 Proteinase activity 21:150 Protein-coupled receptor 27:821 G-Proteine kinase C activity 21:638 Proteins

Protein-tyrosine kinase activity 27:842 offlavonoid aglycones 27:842 of glycosides 27:842 ofKoelreuteria henryi

Protein-tyrosine kinase inhibitory activities

Proteolytic activity 30:841 Proteolytic systemin inactivation

Protium kleinii 30:206 anti-inflammatory effect of 30:206 antinociceptive effect of 30:207 Protocatechuic acid (3,4-dihydroxybenzoic acid) 29:589 effects on

Proton pump inhibitors (PPIs) 25:612 Proton-translocating NADH:Q oxidoreductase 28:435 high-affinity inhibitors

Protozoocidal activity 30:329,741,742 against Leishmania 30:329 against Plasmodium 30:329 against Tryponosoma 30:329 genus Baccharis 30:741 in vitro 30:329 of neo-clerodane diterpenoids 30:742 ofquinone derivative 30:329 Protozoocidal compounds 30:740 use of

Proxyelocytic leukaemia (HL-60)

Prunella vulgaris 30:401 antiviral activity of

Psammaplin A (bisprasin) 28:693 effects on Bacillus subtilis

Psammaplysilla purpurea 28:693 antimicrobial activity of 28:693 as tyrosine kinase inhibitor

Pseudobersana mossambicensis 20:478 bioactive steroids from

Pseudoguaiane 11 a,13-dihydrohelenalin acetate 29:90 activity in CRO assay system

627 against cytomegalo virus 30:627 against human immunodeficiency virus-1 30:627 against influenza virus 30:627 as virucidal agents 30:627 retroviral activity of 7:421 Pseudolaric acid B 13:653

Pseudomonas aeruginosa 30:739 antibacterial activity against 30:739 antifungal activity against

Pseudorabies virus 30:404 in vitro replication of 30:404 role ofheparin 30:404 PSII inhibitors 26:368,371 PSK in mitosis 25:377 PSK-receptor 25:378 PSK-a activity 25:378 Psoriasis 30:484 use of lc~,25(OH)2D3 30:484 Psychiatric disorders 30:369 anorexia 30:369 bipolar disorder 30:369 bulimia 30:369 effect of circadian activity on 30:369 obsessive compulsive disorder 30:369 panic disorder 30:369 schizophrenia 30:369 seasonal effective disorder 30:369 unipolar depression 30:369 Psychodelic drugs 26:820 cocaine as 26:820 morphine as 26:820 semisynthetic LSD as 26:820

Psychovegetative disorders 22:643,684 Psycotria colorata 30:205 to relieve abdominal pain

Puberulin A 26:243,244 as PAF-induced inhibitor

Pulegone 29:83 activity in AM assay system 29:83 Pulmericin 16:299 antifungal activity of 16:299 antileukemic activity of 16:299 cytotoxic activity 16:299

Pulmonary vascular injury 30:70 role of serine protease in 30:70 role of thrombin

Pumiliotoxin alkaloids 27:238,239 alIo-PTX 323 B alkaloid 27:249,250 biological activity of

Punta Toro virus 30:411 treatment of 30:411 Purifying blood 26:50 Herniaria hirsuta in 26:50 Purine receptors

Putative receptor proteins 25:398 Putative satiety factor 24:910 effect of cholecystokinin 24:910 Pyranocoumarin 27:429 biological activity

Pyranoid carbasugars 29:466 as cellular messengers 29:467 as insulin release mediators 29:467 biological activities of 29:466 effects on glycosidase enzyme 29:467 effects on glycosyltransferase enzyme 29:467 galactosyltrans ferase inhibition by

Pyridoacridine alkaloids 28:639 cytotoxic effects on KB cells

524 glycosidase inhibitors of 10:524 Pyrrolomycin antibiotics 25:794 Pytressin-induced coronary spasm

antileukaemic activity of

4'-Quercetagetin (6-hydroxy quercetin hexahydroxyflavone) (flavonol) 29:573 effects on

4'-pentahydroxyflavone) 29:578;30:208,749 analgesic effect of

Quercetin 3-O-c~-L-arabinopyranoside 28:64 anti-oxidant activity

Quercetin 3-O-c~-L-rhamnopyranoside 28:64,65 anti-oxidant activity of

Quercetin 3-O-[3-D-galactopyranoside 28:64 anti-oxidant activity

O-galloyl)-glucoside 29:580 effects on ACE

Quercetin-3-O-ot-L-rhamnopyranoside 28:64 anti-oxidant activity

Quercitrin (quercetin-3-rhamnoside) 29:581 effects on ACE

Quillaia 26:55 of adjuvant activity 26:55 Quinidine 25:347 Quinine 25:344

290 antitumor activity of 10:117 inhibitor of DNA

Quinoline drugs 25:348 Quinoline drug family

Quinoline-based antimalarials 25:344 Quinoline-ring antimalarial drugs 25:327 Quinolines 25:327

Quinolizidine derivatives 27:284,285 testing against Mycobacterium tuberculosis

541-544 as antiviral

Quinone methides 30:694 antiplasmodial activity of 30:694 Quinones

Rabidaea platyphylla 22:513 for epilepsy 22:513 Rabies virus 30:409 inhibitor of 30:409 Rabies virus infection 30:409 in chicken-embryo-related cells 30:409 Rabies virus replication 30:409 in nerve fibers

Rachitic bone healing potencies 484 of vitamin D2 30:484 of vitamin D3 30:484 of vitamin D4 30:484 of vitamin D5 30:484 of vitamin D6 30:484 of vitamin D7

Radical scavenging activity 23:362 of coumarin 23:335

Radioligands 30:814 from brain membrane synaptosomes

Ranitidine 25:612,617 rANP-triggered signal transduction

Raphe nuclei 30:368 role in cognitive functions

Ras oncogenes 22:621 Rat brain synaptosomes 30:807 p-affinity

Rat mammary carcinogenesis model 30:592 cancer chemopreventive activity

Rat serum vitamin D-binding protein (DBP) 30:494 binding assay for

Rebaudioside A 29:101 activity in TPA bioassay system

TPA bioassay system

8-Receptor 22:296 ~-Receptor 22:296 8-Receptor affinity 30:814 binding properties of 30:814 ~t-Receptor affinity 30:814 binding properties of 30:814 of glycopeptide 30:814 8-Receptor agonists

K-Receptor agonists 30:797,806 pharmacological activity of

-Receptor agonists 30:797 pharmacological activity of 30:797 8-Receptor antagonists 30:797 pharmacological activity of

K-Receptor antagonists 30:797 pharmacological activity of 30:797 ~t-Receptor antagonists 30:797 pharmacological activity of 30:797 Receptor binding 27:377 Receptor binding assay 30:810 in vitro 30:810 mouse vas deferens (MVD) activity in 30:810 of guinea-pig ileum (GPI) 30:810 Receptor binding properties 30:815 of Tyr-D-Ala-Phe-[[3-D-Glc(OAc)4]Tyr-Pro-Ser-NH2 30:815 of Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2 (deltorphin C) 30:815 of

OAc)4]-Gly-NH2: 30:815 of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 (deltorphin C) 30:815 of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr([3-D-Glc)-Gly-NH2 30:815 of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr

c )-Val-VaI-Gly-NH2

Receptor tyrosine kinase (RTK) 25:512

Receptors 27:363;30:421 and cell-cell adhesion 30:421 and cell-cell communication 30:421 antigenic determinants of 30:421 for bacteria 30:421 ofchiral proteins 27:363 with enzymatic activity 27:824 without enzymatic

Recombinant prourokinase (pro-UK) 30:839 as fibrinolytic enzymes

Recombinant tissue-type plasminogen activator 30:839 as fibrinolytic enzymes 30:839 Red wine 27:430 biological activity of 27:430 Redox enzymes

Redox inhibitors 30:225 of 5-1ipoxygenase

Repandusic acid (hydrolysable tannin) 29:573 effects on HIV-1 protease 29:573 Repellent properties 28:395 of Amblyomma variegatum 28:395 Reperfusion injuries 30:224 role of free radicals

Rescorcinolic lipids 30:165-167 effects on enzymatic activity 30:165-167 interaction with proteins

Reserpine 25:538 as immunosuppressive drug

Resistance-modifiers 30:595 antimalarial drugs as

Resistant Plasmodium species 30:595 in chloroquine sensitivity

Resorcinolic lipids 30:119,158,160,162-164 as antifungal fluids 30:160 as growth reulators 30:162-163 as hair restoration-lotion 30:160 used in gingival infections

Respiratory ailments 24:847 Respiratory depression 30:799 due to analgesic alkaloid 30:799 Respiratory disorder 30:224 role of free radicals in 30:224 Respiratory infection 30:408 Respiratory syncytial virus 30:395 Respiratory toxins 24:1002,1063 Respiratory tract infections 26:50 Herniaria hirsuta in 26:50 Response decay mechanism 25:491 Response modifiers

Resveratrol 27:430 biological activity of 27:430 Resveratrol 28:582 effects in LLC-bearing mice 28:582 effects on tumor

597 treatment of 30:597 use of Hernandia moerenhoutiana in 30:597 use of Hernandia nymphaeifolia

596 antimalarial activity of 30:595 antiplasmodial activity of 30:596 as platelet aggregation inhibitor 30:594 effect on antiplasmodial activity 30:596 Retinal 29:111;30:520,521 activity in AM bioassay system 29:111 in visual signal transduction 30:520 Retinoic acid 29:111 activity in AM, EBV, skin-1, ODC bioassay systems 29:111 Retinoic acid 30:493,498,521 in cell differentiation 30:521 in development 30:521 in growth regulation 30:521 Retinoid retinol 29:111 activity in AM

Retinol acetate 29:111 activity in AM bioassay system

Retinol palmitate 29:111 activity in AM bioassay system 29:111 Retroviral enzymes 30:397 inhibitor of

408 causative agent of immunodeficiency syndrome 30:394 inhibitor of

Rett's disorder (RTT) 30:372,373,384 by mutations in MECP2 gene 30:373 genetic basis of 30:373 Reutericyclin 28:127 as antibiotic

Reverse transcriptase 30:226,395,397 role in HIV replication cycle 30:226 role in viral replication

Rhazinilams 29:362 as microtubule poisons

Rheedia gardneriana 30:207 antinocicieptive effect of 30:207 Rheumatism 26:50 Herniaria hirsuta in 26:50 Rheumatism 30:192,691 use of non-steroidal antiinflammatory drugs (NSAIDs) 30:192 use of prostaglandin inhibitors 30:192 Rheumatoid arteriosclerosis 30:70 Rheumatoid arthritis 21:152;22:310; 26:170,486;30:70,204,225 in treatment of CPH82 26:170 in rats 30:204 reagent-induced 30:204 treatment of 30:225 use of Kalopanax pictus

Rhoifolin (5, 4'-dihydroxy -7-rhamnosyl-glucosyl-flavone) 29:573 effects on HIV-1 protease 29:573 Rhombenone 24:456 FPTase inhibition by

Ricinoleic acid 30:193 analgesic action of 30:193 Rickettsial pathogens 28:394 Cowdria ruminantium as

Rifamycin-type macrolides 24:545,546 antiviral microbial-derived compound 24

Rift valley fever infection 30:411 treatment of

Rimantidine 27:108 for treatment of influenza in infections

814 activity of deltorphin B in 30:807 of glycopeptide 30:814 RNA virus 30:394 arenavirus type of 30:394 bunyavirus type of 30:394 coronavirus 30:394 influenza virus 30:394 measles virus 30:394 parainfluenza virus 30:394 picornavirus type of 30:394 rabies virus 30:394 reovirus type of 30:394 rotavirus type of

RNA-dependent RNA polymerase activity 30:407 virion-associated

RNA-directed DNA-polymerases 29:127 inhibition by Sf-9 cell line 29:33 activity in mam-3assay system 29:100 antileukemic activity 8:18 Sarcoptes mites 28:410 cause of human scabies 28:410 symptoms

Sarcoptes scabiei 28:409 cause of mange mites 28:409 cause of scabies

Sargasm horneri 30:400,405 anti-CMV activity of 30:405 polysaccharide (PS) from 30:400 Sarkomycin 8:150 as antitumor agent 8:150 Satratoxins 30:743 antiviral activity of

204 Scavenging effects 23:443 of tannic acid 23:443 SCH 207278 24:451 FPTase inhibition by 24:451 Schisandra 26:183 display platelet activating factor antagonist activity 26:183 effect on cardiovascular system 26:183 effect on heart rate 26:183 for treatment of hepatitis

Schisandrol A 26:245 as PAF-induced inhibitor

Schistosomiasis (Bilharzia) 7:405

Schistosomicidal activity 1:545 Schizonticidal drug 26:837 Schizophrenia

101 activity in CRG bioassay system 29:101 from Scoparia dulcis

Scropolioside A 29:84 activity in TPA assay system 29:84 Scrovalentinoside 29:84 activity in TPA assay system

Scutellaria baicalensis 30:55,56,69, 254,289 in allergric inflammatory disease

431 SDB 21:695 inhibitory effect of 21:695 SDC 21:695 inhibitory effect of 21:695 SDZ-249-665 30:201 antinociceptive activity of 30:201 anti-hyperalgesic activity of 30:201 Seasonal affective disorder 30:369 effect of circadian activity on 30:369 Seaweeds 30:404 anti-CMV activity of

activity in EBV assay system 29:100 1,2-Secoemetine derivatives 6:485 amoebicidal activity of 6:485 Secoiridoids 26:330 antimicrobial activity of 26:330 Second messenger 25:516 Secondary metabolites 28:3,432,617 acaricidal activity of 28:432 biological activity of 28:617 Secondary metastatic tumor growth 30:64 effect of triterpenoids on

599 arnica as 22:559 Artocarpus heterophyllus as

Basilicum polystachyon for 22:514 Sedative activity 21:673 Sedative in convulsions 22:518 Crocus sativus L. for 22:518 Sedative in epilepsy 22:535 Withania somnifera L. as 22:535 g-Selective agonist 30:807 dermorphin 30:807 8-Selective antagonist

Tyr-Tic-Phe-NH2

Selective antitumor activity 15:355 Selective cytotoxicity 13:648 8-Selective opioid agonist 30:817 deltorphin B 30:817 g-Selective opioid peptide 30:802 8-Selective opioid peptide

of ICI 19944 30:811 ofk opioids 30:811 8,g-Selectivity 30:819 in vivo 30:819 of glyco analogues

Semilicoisoflavone B 28:229 biological activity of 28:229 Semiochemicals

Semisynthetic LSD 26:820 as psychodelic drug

10-dihydro xy-7-methoxy-naphtho

Sendai virus infection

Sensory neurons 30:194 hyperpolarisation of 30:194 8er264 inhibitors

Serine 27:850 activitiy of

Serine 30:836 c~2-macroglobulin inhibition by

Serine protease inhibitor proteins 29:617 arrowhead PIs API-A & API-B as

Cp-thionin as 29:617 effects on barley malt cysteine endoproteinases 29:617 effects on chymotrypsin 29:617 effects on subtilisin 29:618 effects on subtilisin

Eleusine double-headed TRY-~x-amylase inhibitor I-2 as 29:617 from Brassica nigra 29:618 from Brassica napus 29:618 from Cassia fistula 29:617 from Eleusine coracana 29:617 from Hordeum vulgare 29:617 from Phaseolus angularis

from Sagittaria sagittifolia 29:617 from Sinapis arvensis 29:618 from Vigna unguiculata 29:617 Hordeum lipid transfer proteins as

840 blood clotting factors as 29:570 cathepsin G as 29:570 chymase as 29:570 chymotrypsin as 29:570 granzymes as 29:570 in angiogenesis 29:570 in blood clotting 29:570 in cytosolic proteolysis 29:570 in digestion 29:570 in inflammation 29:570 in proprotein processing 29:570 in tissue remodelling 29:570 kallikrein as 29:570 plasmin as 29:570 prolyl endopeptidases as 29:570 role in blood coagulation 30:70 role in platelet activation 30:70 role in pulmonary vascular injury

Serine proteases (subtilases) 25:388 cysteine proteinase inhibitor 25:370 poly phenol oxidase 25:370 serine proteinase inhibitor

Serine proteinase inhibitor I 25:370 as defense proteins

Serine-threonine-specific receptor protein kinases

Serotonergic innervations 30:377 autoradiographic imaging 30:377 in cerebral cortex 30:377 in neonatal rats by immunohistochemical techniques 30:377 physiological role of 377

Serotonergic neurons 30:368,376 in raphe nuclei 30:376 role in 30:regulation of neurogenesis

627 as hyperforin inhibitor 30:627 as neurotransmitter 30:367 effect on synaptogenesis 30:378 in apoptosis 30:367 in cell proliferation 30:367 in presynaptic neuron 30:381 morphogenic properties of 30:367 neurochemical connection of 30:368 receptor activity of

-HT) receptors 30:376,378, 382,383 in brain 30:383 in limbic brain regions 30:383 pharmacological aspects of

Serotonin (5-HT) re-uptake inhibitors 30:368 mechanism of

Serotonin (5-HT) synthesis 30:370,376, 377 in autistic children

Serotonin (5-HT) 1AR receptor antagonists 30:378 in posmatal treatment

-HT)sA receptor 30:375 in brain development 30:375 in phenotypic behavioral irregularities 30:375 in purkinje cells 30:375 mRNA expression of 30:375 Serotonin action 30:378 on apoptosis 30:378 on maturation 30:378 on neuronal functioning 30:378 on proliferation

Serotonin agonists 25:531 anticomplementary activity of 25:46 role of cyclic AMP-dependent protein kinase 25:46 delayed-type allergy suppressant activity of 25

Serotonin synthesis inhibitor 30:378 parachlorophenylalanine as

Serum TC 27:420 biological activity of 27:420 Serum transaminase 27:415,417,420 biological activity of 27:415

Serum transaminase activity 25:469 of Curcumia longa L

Serum triglyceride 27:404 biological activity

Sesquiterpene lactone 7:426

Sesquiterpene quinones 5:429 antimicrobial activity of 5:429 cytotoxic activity of

Sesquiterpenoids drimane-type synthesis 29:127 avian myeloblastosis virus (AMV) inhibition by 127 by Jauch 29:127 Sex pheromone

Sexual potency 28:4 ofbroussoflavonol G 28:4 sGOT 30:292 activities of 30:292 sGPT 30:292 activities of 21:654

Shikimic acid derivatives 29:478 antitumoral activity of 29:479 Shinpterocarpin 28:229 biological activity of 28:229 Sialic acids 27:103 biological function of 27:103 model for

Sialyltransferase activity 16:81 Side effect 30:194,799 of analgesic alkaloid 30:799 of opioids

Sigmoidin A 28:229 biological activity

Sigmoidin B 28:229 biological activity of 28:229 Signal reception 30:377 in autistic children 30:377 Signal transduction mechanisms 25:518 Signal transduction pathways

Signal transductors/activators of transcription (STATS) 25:519 Silandrin 26:255 as antihepatotoxic agent 26:255 Silchristin 26:255 as antihepatotoxic agent 26:255 Sildenafil 30:155 used for erectile dysfunction

Silymonin 26:255 as antihepatotoxic agent 26:255 Simocyclinon 29:319 antibiotic activity of 29:319 cytostatic effects of 29:319 Sindbis virus 17:135

Sinomenine 25:472,476 hepatoprotective effect

glycoside) 29:590 effects on PEP 29:590 Skin cancer 5:747 Skin diseases 30:732 Skin inflammation 30:323 anthrones used for 30:323 SKK Moth 1:704-706 juvenile hormone from

Slaframine 27:252 biological activity

Slaframine alkaloids 27:250,255 as muscarinic agonist 27:255 Sleeping sickness

Smenoquinone 5:434,425 antimicrobial activity of

Smooth muscle relaxation 24:875-925 as biological action 24:875 of Kampo medicines

Snake bite 30:691 treatment of 30:691 use of Crossopetalum gaumeri 30:691 Sobrerol 29:83 activity in mam-2 assay system 29:83 activity in GST assay system 29:83 activity in RAS assay system 29:83 Social phobia

Sodium salt of caffeic acid tetramer 24:742,743 anti-HIV activity of 24:742 Soilborne fungi 21:181 bioactive metabolites from

Soilborne phytopathogens 21:182 biological control of 21:182 Solandelactones 24:455 FPTase inhibition by

Solanidane-induced teratogenicity 23:573 Solid tumors neovasularization 25:593 Somatostain 25:265 as A~ adenosine agonists

Somatostatin receptor 21:72;22:26; 25:530 type of G-protein-linked receptor 25:530 Sonodione 30:566 from Hernandia sonora 30:566 Sores 30:616 tricyclic acylphloroglucinols

Sorivudine 24:474,486 as anti-viral agent 24

Sorocein F 28:230 biological activity of 28:230 SOS chromotest 22:623 Soyabean saponins 25:222,223 hypocholesterdemic effects

Soyasaponins 27:398 anti-obesity action of 27:398 biological activity of 27:399 Soybean trypsin inhibitor (SBTI)

Spasmolytic activity 23:358 ;28:257,293; 30:264,561,748 of Hernandia moerenhoutiana 30:561 ofHernandia voyronii 30:561 of imperatorin 23:350,358 of plant polyphenols 28:257,293 of Thymus satureioides 30:264 on guinea pig ileum 30:748 on smooth muscles

Specionin 10:425 antifeedant activity of 10:425 Spermicidal activity 26:53 of Gypsophila paniculata

Sphingolipid receptor Ca 2+ channels 25:535 Sphingolipid receptors 25:534 Sphinxolide 10:153;17:17 antitumor activity of 17:17 Spider mite 1:702 hatching inhibitor

Spiroalkyl analogs 28:357 biological activity

Spirulina platensis 30:399,404,408 anti-influenza activity of 30:408 biological activity of 30:404 calcium spirulan from 30:399 polysaccharide (PS) from

Spleen/adipose tissue weight 30:56,57, 66 1203 effect of fucoidan on 30:56,57 effect of oleic acid on 30:65 Spontaneous apoptosis 26:926 Spontaneous metastasis

Squarroside A 26:31,50 immuno-modulatory effect of 26:31 from Vaccaria segetalis

Squash family serine protease inhibitors 29:614 BD-TI-II as 29:614 CMTI-I as 29:614 CMTI-III as 29:614 CMTI-IV as 29:615 CPGTI-I as 29:615 CPTI-II as

factor XIIa, kallikrein, trypsin 29:615 effects on lysyl endopeptidase 29:614 effects on trypsin 29:614 effects on trypsin 29:615 effects on trypsin 29:616 effects on Xa, XIIa, kallikrein, plasmin, trypsin 29:614 ELTI-I as 29:615 from Bryonia dioica 29:614 from Citrullus vulgaris 29:614 from Cucumis melo 29:614 from Cucumis melo 29:614 from Cucumis sativus 29:614 from Cucurbita maxima 29:614 from Cucurbita maxima 29:614 from Cucurbita pepo 29:615 from Cucurbita pepo 29:615 from Ecballium elaterium 29:615 from Echinocystis lobata 29:615 from Lagenaria leucantha 29:615 from Luffa acutangula 29:615 from Luffa cylindrica

Cucurbitaceae) 29:616 from Tricosanthes 29:616 HMTI-I as 29:614 LATI as 29:615 LATI-II as 29:615 LLDTI-I as 29:615 LLDTI-II as 29:615 MCEI-I as

Stachenone 29:101 activity in EBV bioassay system 29:101 Standishinal 29:100 activity in EBV assay system 29:100 Standishinal diacetate 29:100 activity in EBV assay system

Staphyllococcus aureus 30:693 minimal inhibitory concentration (MIC) of

Staphyllococcus epidermidis 30:693 minimal inhibitory concentration (MIC) of

Staphyllococcus saprophyticus 30:693 minimal inhibitory concentration (MIC) of

Staphyllococcus warnieri 30:693 minimal inhibitory concentration (MIC) of

Staphylococcus aureus 30:628,739 antibacterial activity against 30:739 antibacterial properties of 30:628 antifungal activity against

Starfish fertilisation inhibitor 28:712 callyspongin B as 28:712 Stavudin 24:474,486,488 as anti-viral agent 24:474

Steganes 29:360,399 cytotoxicity of 29:360,399 tubulin assembly inhibition by 29:360 antitubulin activity of 29:399,400 microtubules assembly inhibition by

Sterculia urens Roxb. 30:405 antiviral activity of 30:405 Steroid hormones 27:823 Steroid saponins 7:426

teratogenic metabolites of 7:21-24 toxic

cardiac active steroids

Sterol biosynthesis 25:303 inhibitor of 25:303 6a-Sterol sulfate 28:702 cytotoxicity against

Sterol sulfates haplosamate A 28:703 as HIV-1 integrase inhibitor 28:703 Sterols 25:43 antitumor activity of 25:43 antiinflammatory activity of 25:43 Stevia

Stevia extract 27:307,310,314 for diabetics

Stevia leaves 27:315 immunological activity

Stevia plant 27:315 allergenic activity

Steviol 27:304,305,307,312 acute toxicity tests of 27:307 effect on fertility 27:312 mutagenicity tests with

TPA bioassaysystem 29:101 activity in skin-1 bioassay system 29:101 acute toxicity tests of 27:307 allergenicity problems of 27:315 chronic toxicity studies of 27:306,307,308 effect on fertility 27:309,310 for phenylketonuria 27:315 mutagenicity tests for

Stigmasterol 30:208,505,570,719 analgesic effect of

Stilbene derivatives 27:405,409;28:579 biological activity of 27:405,409 in LLC-bearing mice 28:579 tumor growth inhibition by 28:579 Stimulatory 24:845 biological activity 24:845 Stimulant agent 23:642 ofteucrium sp

Stimulus-response mechanisms 25:515 Streptococci 29:535 pathogenicity of 29:535 serological groups

Streptokinase/streptodomase 25:271 Streptolygidin 28:130 antibiotic activity of 28:130 as bacterial RNA polymerase 28:inhibitor 130 as terminal DNA transferase

Striga asiatica 30:162 infection with

ofbioactive metabolites 21:251 of scopadulan-type diterpenoids

Structure activity relationship studies (SAR) 30:195,494,800 of anandamide 30:196 of aspirin 30:195 ofopioid analogues 30:800 of vitamin D analogues 30:493 Structure dereplication 29:658 bioactive natural product database in 29:670 of melanin inhibition

Strychnine 25:530 as immunosuppressive drug 25:530 Strychnopentamine 26:1062 anticancer activity

Strychnos bisindole 26:1062 anticancer activity

Strychnos monoindole 26:1061 anticancer/protozoal

Subacute toxicity 27:307 from animals 27:307 of stevioside

588 effects on furin 29:588 SUDHL-4-1ymphoma 21:138 Sugar cane cystatins 29:593 effects on cysteine proteases 29:593 Suicide inhibition 27:348 of 8'-hydroxylase 27:348 Suicide inhibitors 9

Sulfatobastadin 13 28:695 as endothelin A receptor inhibitor

Sulfide-containing pyrroloiminoquinones 28:685 as antileukaemic agents

Sulfur-containing cyclic peptides 28:678 biological activities of 28:678 cytotoxicity of

Sulphated polysaccharide (PS) 30:398, 400,405 anti-CMV activity of 30:405 anti-HIV activity of 30:398 antiviral activity against HIV 30:400 effect on viral replication 30:400 from marine sources 30:400 inhibitory effect of 30:398 mechanisms of action

Sulphated polysaccharide (PS) extracts 30:399 inhibitory activity of

Sulphonylurea drugs 25:534 Sunflower cystatin phytocystatin 29:593 effects on cathepsin H ficin 29:593 effects on papain 29:593 Sunflower multicystatin 29:593 effects on papain

Supercritical fluid extraction 21:576 Superoxide dismutase

Superoxide dismutase activity 21:669 Suppressing activity 30:308 on cells proliferation

Zizyphus saponin I as 27:41 Zizyphus saponin II

Sweroside 25:471,476 serum ALT activity of 25

Symbiotic marine microorganisms 23:185 bioactive metabolites 23:185 Sympathetic ganglia 30:782 blockade of 30:782 Sympathetic nerve activity 30:787 Sympathomimetic amines 12:411 Synapic potential mediation 28:318 by non-NMDA receptors 28:318 Synaptic actions 30:381 of serotonin

Synaptic dopamine transporters 25:539 Synaptic glycine transporters 25:539 Synaptic serotonin transporters 25:539 Synaptogenesis 30:368,377 effect of serotonergic neurotransmission on 30:368 role in rodents 30:377 role of serotonin in 30:377 Syndrome type-lA 26:1130 adipose tissue distribution as 26:1130 cerebellar dysfunction as 26:1130 liver insufficiency as 26:1130 peripheral neuropathy as 26:1130 psychomotor retardation as

Synergistic activity 21:673 Synergistic effect 21:608,611; 30:498,596 ofhervelines B 30:596 ofhervelines C 30:596 of retinoids 30:498 of vitamin D derivatives 30:498 Synergistic interaction 21:698 of acyclovir(ACV) 21:698 ofganciclovir (GCV) 21:698 with ganciclovir

Synergistic purgative actions 30:306 of rheinanthrone 30:306 of aloe-emodin-anthrone 30:306 Synthetic pharmacological agents 30:224 antioxidant activity of 30:224 Synthetic podolactones 28:484 allelopathic activity

Synthetic psychotropic agents 24:1093 Syringaresinol 24:741 anti-platelet aggregation activity of

Systemic wound response protein 25:402 Systemin activity 25:373 assay for

]-Val-Val-Gly-NH2 30:815 receptor binding properties of

receptor binding properties

Tyr-Pro-Ser-NH2 (deltorphin C) 30:815 receptor binding properties of

-D-Glc)-Gly-NH2 30:815 receptor binding properties of

OAc)4]-Gly-NH2 30:815 receptor binding properties of

-D-Glc)-Tyr-Pro-Ser-NH2 30:815 receptor binding properties of

-D-G lc )-V a 1-V al-Gly-NH2 30:815 receptor binding properties of

Tyrosinase inhibitory activity 21:587 Tyrosine kinase

Tyrosine-specific kinase 19:178 inhibitor of

Tyr-Tic-NH2 30:809 activity in functional bioassay

Tyr-Tic-Phe-NH2 30:806 as 5 selective antagonist 30:806 U2 66 myeloma cell 25:273 UCN-01-UCN-02 12:386 antitumor activity of 12:395 protein kinase inhibitor

Ulapualides A 19:609 antifungal activity

Unsaturated carbapyranoses 29:475 as enzyme inhibitors 29:475 as herbicidal 29:475 biological properties of 29:475 Unsaturated ketonucleosides 4:253 tumor inhibition by

U-plasminogen activator (u-PA) 30:844 Urdamycin A 11:134 antifungal activity of 11:134 antitumor activity

Ureterolithiasis-drug-therapy 27:382 Urinary tract infections 26:50 Herniaria hirsuta in 26:50 Urine retention 30:194 as opioid's side effect 30:194 Uroterpenol 29:83 activity in mam-2 assay system 29:83 activity in RAS assay system

Ursane triterpene 29:585 effect on CHY 29:585 Ursolic acid 28:18,40;29:588 effects on HIV-1 protease 29:575 effects on LELA 29:588 inhibition of HIV-1 protease dimerization by

Ursolic acid methyl ester (ursene triterpene) 29:575 effects on HIV-1 protease 29:575 Usambarensine 26:1062 anticancer activity of 26:1060 Uterine tumor 30:27 effect of pironetin derivatives in 30:27 Uusambarine 26:1062 anticancer activity

Uvaol (triterpene) 29:588 effects on

Urs-12-ene-3,28-diol) (ursene triterpene) 29:575 effects on

Vaccaria segetalis 26:50 imunomodulatory effect of 50 Vaccination 30:408 for respiratory infection

as neuraminidase inhibitors 29:487 as c~-amylase inhibitor 29:486 c~-glucosidase inhibitors of 7:46;10:518 yeast a-glucosidase inhibitor of 10:518 Valinuoctins 24:459 FPTase inhibition by

Valiolamine 13:189,195 yeast c~-glucosidase inhibitor

Valiolamines 29:484 as glucosidase inhibitor 29:484 biological potential of 29:484 in clinical trials 29:484 in treatment of diabetes 29:484 Valproic acid 22:507 Vancomycin 25:791 Vancoresmycin 28:150 activity against gram-positive bacteria

Vanilloid receptor agonist 30:202 olvanil as 30:202 capsaicin as 30:202 structure of

Vanilloid receptor antagonist 30:201, 202 capsazepine as 30

Varicella-Zoster virus 30:394 cause of

Varroajacobsoni 28:387 toxicity of

Varroa mites 28:383

Vascular physiological action 30:55,69 of natural products

Vasodilating activity 21:379 Vasodilator 23:358 scoparone as

Vasodilator effect 25:595 of acetylcholine

Vasodilatory activity 30:275 ofSatujera obovata

Vasoprotective agent 22:443 Vasoprotective effects 28:302 of green tea

Vateamine-2' [3-N-oxide 30:567, 590,595 activity in human cancer cell line 30:589 activity in murine cancer cell line 30:589 as platelet aggregation inhibitor 30:594 cytotoxic effect of 30:589 Veinotonic activities

Veraguensin 26:230 trypanosomicidal activity

Verapamil 25:534,673 as CaZ+-channel blocker 25:487 Vermisporin 28:125 antimicrobial activity

Vernonia amygdalina 28:400 tick toxicity of 28:400 Verrucarins 30:743 arenavirus junin 30:743 herpes simplex virus type II (HSV-2)

Verrucosin 26:228 ofantiviral activity 26:228 Vertebrate toxicity 21:98 Vesicant activity

Vesicular glutamate transporters 25:538 Vesicular monoamine transporter type 2 (VMAT2) inhibitor

Vesicular stomatitis virus (VSV) 30:743,752 replication of 30:743 Vesititol 28:224 anti-microbial activity of 28:224 Vestitol 28:243 anti-Helicobacter pylori activity of 28:243 Veterinary medicine 28:383 for ectoparasites control 28:383 Vetiver grass 28:399 for controlling ticks

Viagra (sildenafil) 25:541 Vicolides 29:89 activity in CTN bioassay system

458 anticancer activity of 14:805 Viral diseases 30:732 Viral DNA 30:226 integration of

 12:332;21:98,193, 263,270,312,398,430,585,589,591, 594,643,659,670,673,675,690;23:59, 216,808;26:217;28:481 ;30 :629 against bone resorption 21:720, 721 against H+,K+-ATPase 21:719 against Staphyllococcus aureus 30:629 mechanism action of 30:225 of (-)-(8,8a-di-epi-swainsonine 12:325 of (-)-swainsonine 12:327 o f (+) cyasterone activity in 29:32 2-deoxy-20-hyroxyecdysone activity in 29:32 14-deoxymuristerone A activity in 29:32 2 [3,3 [3-dihydro xy-513-chole st-7en-6-one activity in 29:32 3 [3,14a-dihydroxy-5 [3-cholest-7en-6-one activity in 29:32 ecdysone activity in 29:32 313-hydro xy-5 [3-cho le st-6-one activity in 29:32 20-hydroxyecdysone activity in 29:32 inokosterone activity in 29:32 Kc cell bioassay as 29:30 makisterone A activity in 29:32 muristerone A activity in 29:32 podecdysone A activity in 29:32 ponasterones activity in 29:32 213,313,513,14 a-tetrahydro x ycholest-7-en-6-one activity in 29:32 2[3,3 ~ ,25-tridihydroxy-513cholest-6-one activity in 29:32 viticosterone E activity in 29:32 Insect control 21:611 Insect juvenile hormone analogues 14:391-397 from thujone 14:391-397 Insect pheromones 11: [415] [416] [417] via diisopropylethanediol esters 11:415-417 Insect repellant 5:757 Insecticidal activity 18:229,704;21:252, 254,262,266,267,269,270,271,278, 285,379,595,611;23:666;667,670, 677,678;24:25,799,845,866;26:231, 232,426,471,479,485;28:477; 30:153-154 activity of (-)-deoxypodo phyllotoxin in 30:589 activity of (-)-hernone in 30:590 activity of (-)-nymphone in 30:590 activity of (-)-yatein in 30:590 activity of (+)-corytuberine in 30:589 activity of (+)-epiaschantin in 30:590 activity of (+)-epimagnolin in 30:590 activity of (+)-epiyangambin in 30:590 activity of (+)-hernovine in 30:589 activity of (+)-laurotetanine in 30:589 activity of (+)-magnoflorine in 30:589 activity of (+)-malekulatine in 30:590 activity of (+)-N-hydroxyhemangerine in 30:589 activity of (+)-N-formylnornantenine in 30:589 activity of (+)-N-formyldehydroovigerine in 30:589 activity of (+)-N-formylovigerine in 30:589 activity of (+)-ovigerine in 30:590 activity of (+)-ovihernangerine in 30:590 activity of (+)-vateamine-2' [3-Noxide in 30:590 activity of 7-formyldehydrohernangerine in 30:589 activity of 7-formyldehydronornantenine in 30:589 activity of 7-formyldehydroovigerine in 30:589 activity of 7-hydroxy-6-methoxy- 1:467,468;2:278,279,286, 289;6:108;7:103,110,121-123; 17:235,244 ;29:87 ;30:193,206 activity in EBV assay system 29:87 activity in Skin 1 assay system 29:87 activity in CRG assay system 29:87 activity in CRO assay system 29:87 activity in AA assay system 29:87 activity in BRK assay system 29:87 activity in CPS assay system 29:87 activity in HTM assay system 29:87 activity in PAF assay system 26:3,4,10,13,15, 18,27,30,42,54,57;30:407 anti-inflammatory activity of 26:27 antiviral activity of 30:407 Saponins 1:305; 402; 7:155, 156, 190, [426] [427] [428] [429] [430] [431] [432] 434, 435; 18:649 ajugasterone C activity in 29:28 amarasterone A activity in 29:28 amarasterone B activity in 29:28 cyasterone activity in 29:28 ponasterone A 2p-glucoside activity in 29:28 pterosterone activity in 29:28 rubrosterone activity in 29:28 sengosterone activity in 29:28 stachysterone C activity in 29:28 capitasterone activity in 29:28 Sarcophytol A 29:100 activity in EBV assay system 29:100 activity in colon-2 assay system 29:100 activity in liver-2 assay system 29:100 activity in lung-1 assay system 29:100 activity in mam-3 assay system 29:100 activity in pancr assay system 29:100 activity in skin-2 assay system 29:100 Sarcophytol B 8:18;29:100 activity in skin-2 assay system 29:100 use of Platycodon grandiflorum